CD163 and cancer: Among CD68+CD163+ TAMs also expressing the recently identified TREM2 marker, we could identify a CXCL10+IRF1+STAT1+ M1-type Mφ population (Cluster 9) (Figures 7A, B) shared between all cancer types (Figure 7C).